A new “opt-out” approach to sexually transmitted infection testing at Planned Parenthood of Orange and San Bernardino ...

The at-home kit, according to the FDA, is the first of its kind to test for chlamydia, gonorrhea and trichomoniasis, three of the most common STIs with symptoms that often go unnoticed.

The U.S. Food and Drug Administration on Friday granted authorization to market the first test that can be performed entirely at home for detecting three sexually transmitted infections (STIs).

It is estimated that trichomoniasis is the most prevalent non-viral STI worldwide, affecting about 2.6 million people in the U.S., according to the CDC.

According to the Centers for Disease Control and Prevention's Sexually Transmitted Infections (STI) Surveillance Report, more than 2.2 million cases of chlamydia and gonorrhea were diagnosed and ...

It is estimated that trichomoniasis is the most prevalent non-viral STI worldwide, affecting about 2.6 million people in the U.S., according to the CDC.

Today, the U.S. Food and Drug Administration granted marketing authorization to Visby Medical for the Visby Medical Women's Sexual Health Test. This is the first diagnostic test for chlamydia ...

The U.S. Food and Drug Administration (FDA) has approved the first-ever testing kit for sexually transmitted infections that can be taken at home without a prescription. But it's not for everyone ...

Data from the Department of Health and Family Health International showed that trichomoniasis had a prevalence rate of 3.18 per cent among more than 2,000 Filipino female respondents in 2002.

At the time, trichomoniasis was detected through “culture or wet mount” laboratory testing. Other curable STIs found among women surveyed in the study were chlamydia (5.75 percent), gonorrhea ...